The $2.5 million judgment handed down by a Philadelphia jury against Johnson & Johnson’s Janssen Pharmaceuticals over allegations that its antipsychotic Risperdal caused a disfiguring injury to an adolescent boy will stand despite the drug maker’s request for a new trial. Judge Ramy Djerassi of the Philadelphia County Court of Common Pleas told Janssen the ruling in the first Risperdal side effects lawsuit to go to trial will stand. The bellwether trial involved the case of now-22-year-old Adam Pledger who developed abnormal breast tissue – a condition known as gynecomastia- after taking Risperdal. The verdict in that case was handed ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.